<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">310119</id>
  <title nil="true"/>
  <common-name>3-[(6,8-dibromo-4-oxoquinazolin-3-yl)methyl]-2-phenylimino-1,3-thiazolidin-4-one</common-name>
  <description>3-[(6,8-dibromo-4-oxoquinazolin-3-yl)methyl]-2-phenylimino-1,3-thiazolidin-4-one is a chemical compound with the formula C18H12Br2N4O2S. With an average molecular weight of 508.20 g/mol, 3-[(6,8-dibromo-4-oxoquinazolin-3-yl)methyl]-2-phenylimino-1,3-thiazolidin-4-one is a heavy molecule.</description>
  <cas>74875-85-7</cas>
  <pubchem-id>63550</pubchem-id>
  <chemical-formula>C18H12Br2N4O2S</chemical-formula>
  <weight>508.2</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-29T05:02:31Z</created-at>
  <updated-at type="dateTime">2026-08-29T05:02:31Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1C(=O)N(C(=NC2=CC=CC=C2)S1)CN3C=NC4=C(C3=O)C=C(C=C4Br)Br</moldb-smiles>
  <moldb-formula>C18H12Br2N4O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C18H12Br2N4O2S/c19-11-6-13-16(14(20)7-11)21-9-23(17(13)26)10-24-15(25)8-27-18(24)22-12-4-2-1-3-5-12/h1-7,9H,8,10H2</moldb-inchi>
  <moldb-inchikey>XZCFYWYNJZMVDT-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">505.90477</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM306012</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[(6,8-dibromo-4-oxoquinazolin-3-yl)methyl]-2-phenylimino-1,3-thiazolidin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0261100</sync-id>
  <structure-inchikey>XZCFYWYNJZMVDT-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>80000800400000000000000048400000000000000000000020000000000000020000020000000002004000000000000000000000000800080000008000000000000080000000000000020000010000000000004800000000000000002000080004000001002100000000400020900000000000001000000000000000000000002810000000000000000000000000100000000000000000000040000000000000000040001080000000020000000090000000000000000000000000000000000000000000108000000800000000000000820000210000800000000000000000002000040000000000000080000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>501440088d12864081801be08128a0220000140083052000003720c0822409cc4c2230d113c000000108410800c0000004600227c08d36010026e43104a1c210c7110c0016904c084090104000720200088425f051211a3640041562502258044c2845270048020061408401dd940009208680708901c0047139286802510012104c00184ff082080c860250ca2c0018b91d8a9244401e0b5420082060c040a440c730100090c00202000968057c2d100ac000028941084818a06e100cc04212a010d8a524d0023381808c04741102c02d010001220050a00d4002040a008300911043100888024000000411d11220a0081000309046040e6108108072030606</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAbAAAAHgAAAIABBgBgAAAAAgIGACgAAAAD
BAgAKAAAAAMCBwAoAAAAAwMGACgAAAADBAcAKAAAAAMDBkAoAAAAAwQGQGgA
AAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEQACAA
AAACBgBgAAAAAgIHQCgAAAADAwZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQG
QCgAAAADBAZAKAAAAAMECAAoAAAAAwIGQGgAAAADAwEGQCgAAAADBAZAaAAA
AAMDAQZAKAAAAAMEIwAgAAAAASMAIAAAAAELAAEAAQIoAgEDIAMEIAQFKAIF
BiAGB2gMBwhoDAgJaAwJCmgMCgtoDAQMAAMNAA0OAA4PaAwPEGgMEBFoDBES
aAwSE2gMExQoAhIVaAwVFmgMFhdoDBcYaAwYGQAWGgAMAAALBmgMEw5oDBgR
aAxCBAAAAAUAAQMEDAYHCAkKCwYGDxAREhMOBhUWFxgREhcEAAAAAAAAABY=
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:17:37Z</structure-indexed-at>
</compound>
